Cell and Gene Roundup: CAR T Breaks New Ground
April 15, 2026
A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression
5 min read
False
April 15, 2026
A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression
5 min read
April 14, 2026
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.
1 min read
April 13, 2026
An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
2 min read
April 10, 2026
MIT-led team develops rapid, non-destructive method to predict stem cell quality during manufacturing
1 min read
April 9, 2026
New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included
1 min read
April 8, 2026
Circular single-stranded donors help recombinases bypass immune defenses, unlocking in vivo gene insertion
2 min read
April 7, 2026
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
1 min read
April 6, 2026
Engineered immune cells clear amyloid and improve brain health in mice, offering a new direction for neurodegenerative therapy
1 min read
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
False
False
False